The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial
Anees Bahji(University of Calgary), M. Eugenia Socías(University of British Columbia), Didier Jutras‐Aswad(Centre Hospitalier de l’Université de Montréal), Bernard Le Foll(Centre for Addiction and Mental Health), Ron Lim(University of Calgary), Paxton Bach(University of British Columbia), JinCheol Choi(British Columbia Centre on Substance Use), Gabriel Bastien
Cited by 4
Related Papers
Genetics of dopamine receptors and drug addiction: a comprehensive review
|Behavioural Pharmacology|2009|396
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes
|The Canadian Journal of Psychiatry|2024|329
Tobacco and nicotine use
|Nature Reviews Disease Primers|2022|293
Characterization of Environmental Sources of the Human and Animal Pathogen <i>Cryptococcus gattii</i> in British Columbia, Canada, and the Pacific Northwest of the United States
|Applied and Environmental Microbiology|2006|238
Identification of Dopamine D1–D3 Receptor Heteromers
|Journal of Biological Chemistry|2008|230